Accurate Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-115
Closed -$21.8K 960
2022
Q4
$21.8K Buy
+115
New +$18.8K 0.01% 657
2022
Q1
Sell
-213
Closed -$1.06M 190
2021
Q4
$1.06M Buy
213
+15
+8% +$4.39K 0.86% 20
2021
Q3
$1.06M Buy
+198
New +$73K 0.93% 18

Other funds holding MRNA

Accurate Wealth Management's MRNA Position: Q1 2023 in Review

Accurate Wealth Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 115 shares — an estimated $21.8K sold.

Accurate Wealth Management first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $1.06M in Q3 2021. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Accurate Wealth Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Accurate Wealth Management sold 115 Moderna shares in Q1 2023, an estimated $21.8K.
  • Accurate Wealth Management first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Accurate Wealth Management's Moderna position peaked at $1.06M in Q3 2021.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.